Orgenesis Inc. is a biotechnology company which engages in the development, manufacturing, and provision of technologies and services in the cell and gene therapy industry. It established the POCare Network to bring academia, hospitals, and industry together to make innovations more affordable and accessible to patients.
| Ownership Public Company |
| Stock ORGS (NASDAQ) |
Orgenesis Inc. is a biotechnology company focused on the cell and gene therapy industry, providing technologies and services through its POCare Network to make therapies more affordable and accessible
Orgenesis identifies and partners with early-stage biotechnology developers to bring promising new therapies in-house, creating a pipeline of POCare Therapies through a global network of academia, hospitals, and industry.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with Orgenesis Inc.